Pilkington V, et al. Meta-analysis of the risk of Grade 3/4 or serious clinical adverse events in 12 randomised trials of PrEP (n = 15,678). Abstract O143, HIV/Drug Therapy Glasgow 2018.
BCG-hervaccinatie beschermt niet tegen persisterende M. tuberculosis-infectie
sep 2025 | Tuberculose, Vaccinatie